An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder.

Carvalhal, Adriana S

An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. [electronic resource] - The Journal of clinical psychiatry Apr 2003 - 421-4 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0160-6689

10.4088/jcp.v64n0411 doi


Adolescent
Adrenergic Uptake Inhibitors--adverse effects
Adult
Ambulatory Care
Antidepressive Agents--adverse effects
Comorbidity
Depressive Disorder--diagnosis
Female
HIV Seropositivity--epidemiology
Humans
Hyperhidrosis--chemically induced
Male
Middle Aged
Morpholines--adverse effects
Nausea--chemically induced
Psychiatric Status Rating Scales
Reboxetine
Sleep Initiation and Maintenance Disorders--chemically induced
Treatment Outcome